If Teva were approved tomorrow, the downside would be a lot lower than $18/share. Of course that's not going to happen.
That didn't happen, tomorrow is today :) kidding aside, if "tomorrow" is the next few weeks like Teva thinks, I suppose downside would still be a lot lower than $18/share. Agree?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.